148 related articles for article (PubMed ID: 35324842)
1. Immunohistochemical Expression of TGF-β1 in Kidneys of Cats with Chronic Kidney Disease.
Uehara Y; Furusawa Y; Islam MS; Yamato O; Hatai H; Ichii O; Yabuki A
Vet Sci; 2022 Mar; 9(3):. PubMed ID: 35324842
[TBL] [Abstract][Full Text] [Related]
2. Investigation of the transforming growth factor-beta 1 signalling pathway as a possible link between hyperphosphataemia and renal fibrosis in feline chronic kidney disease.
Lawson JS; Syme HM; Wheeler-Jones CPD; Elliott J
Vet J; 2021 Jan; 267():105582. PubMed ID: 33375963
[TBL] [Abstract][Full Text] [Related]
3. The cat as a naturally occurring model of renal interstitial fibrosis: Characterisation of primary feline proximal tubular epithelial cells and comparative pro-fibrotic effects of TGF-β1.
Lawson JS; Liu HH; Syme HM; Purcell R; Wheeler-Jones CPD; Elliott J
PLoS One; 2018; 13(8):e0202577. PubMed ID: 30138414
[TBL] [Abstract][Full Text] [Related]
4. Characterisation of feline renal cortical fibroblast cultures and their transcriptional response to transforming growth factor β1.
Lawson JS; Syme HM; Wheeler-Jones CPD; Elliott J
BMC Vet Res; 2018 Mar; 14(1):76. PubMed ID: 29523136
[TBL] [Abstract][Full Text] [Related]
5. Urinary transforming growth factor-beta1 in feline chronic renal failure.
Arata S; Ohmi A; Mizukoshi F; Baba K; Ohno K; Setoguchi A; Tsujimoto H
J Vet Med Sci; 2005 Dec; 67(12):1253-5. PubMed ID: 16397385
[TBL] [Abstract][Full Text] [Related]
6. Urinary active transforming growth factor β in feline chronic kidney disease.
Lawson JS; Syme HM; Wheeler-Jones CP; Elliott J
Vet J; 2016 Aug; 214():1-6. PubMed ID: 27387717
[TBL] [Abstract][Full Text] [Related]
7. Low-dose of multi-glycoside of Tripterygium wilfordii Hook. f., a natural regulator of TGF-β1/Smad signaling activity improves adriamycin-induced glomerulosclerosis in vivo.
Wan YG; Che XY; Sun W; Huang YR; Meng XJ; Chen HL; Shi XM; Tu Y; Wu W; Liu YL
J Ethnopharmacol; 2014 Feb; 151(3):1079-1089. PubMed ID: 24362077
[TBL] [Abstract][Full Text] [Related]
8. Decreased circulating transforming growth factor-beta (TGF-β) and kidney TGF-β immunoreactivity predict renal disease in cats with naturally occurring chronic kidney disease.
Piyarungsri K; Chuammitri P; Pringproa K; Pila P; Srivorakul S; Sornpet B; Pusoonthornthum R
J Feline Med Surg; 2023 Dec; 25(12):1098612X231208937. PubMed ID: 38131312
[TBL] [Abstract][Full Text] [Related]
9. Transforming Growth Factor-β1/Smad Signaling in Glomerulonephritis and Its Association with Progression to Chronic Kidney Disease.
Chalkia A; Gakiopoulou H; Theohari I; Foukas PG; Vassilopoulos D; Petras D
Am J Nephrol; 2021; 52(8):653-665. PubMed ID: 34496361
[TBL] [Abstract][Full Text] [Related]
10. Profibrotic effects of angiotensin II and transforming growth factor beta on feline kidney epithelial cells.
van Beusekom CD; Zimmering TM
J Feline Med Surg; 2019 Aug; 21(8):780-787. PubMed ID: 30345862
[TBL] [Abstract][Full Text] [Related]
11. Central role of dysregulation of TGF-β/Smad in CKD progression and potential targets of its treatment.
Chen L; Yang T; Lu DW; Zhao H; Feng YL; Chen H; Chen DQ; Vaziri ND; Zhao YY
Biomed Pharmacother; 2018 May; 101():670-681. PubMed ID: 29518614
[TBL] [Abstract][Full Text] [Related]
12. VEGF -460 genotype plays an important role in progression to chronic kidney disease stage 5.
Summers AM; Coupes BM; Brennan MF; Ralph SA; Short CD; Brenchley PE
Nephrol Dial Transplant; 2005 Nov; 20(11):2427-32. PubMed ID: 16046504
[TBL] [Abstract][Full Text] [Related]
13. Increased glomerular and tubular expression of transforming growth factor-beta1, its type II receptor, and activation of the Smad signaling pathway in the db/db mouse.
Hong SW; Isono M; Chen S; Iglesias-De La Cruz MC; Han DC; Ziyadeh FN
Am J Pathol; 2001 May; 158(5):1653-63. PubMed ID: 11337363
[TBL] [Abstract][Full Text] [Related]
14. Urinary cytokine levels in apparently healthy cats and cats with chronic kidney disease.
Habenicht LM; Webb TL; Clauss LA; Dow SW; Quimby JM
J Feline Med Surg; 2013 Feb; 15(2):99-104. PubMed ID: 22989558
[TBL] [Abstract][Full Text] [Related]
15. Let-7c-5p Is Involved in Chronic Kidney Disease by Targeting TGF-
Wang Z; Zhou C; Sun Y; Chen Y; Xue D
Biomed Res Int; 2020; 2020():6960941. PubMed ID: 32626757
[TBL] [Abstract][Full Text] [Related]
16. Roles of TGF-beta1 and apoptosis in the progression of glomerulosclerosis in human IgA nephropathy.
Chihara Y; Ono H; Ishimitsu T; Ono Y; Ishikawa K; Rakugi H; Ogihara T; Matsuoka H
Clin Nephrol; 2006 Jun; 65(6):385-92. PubMed ID: 16792132
[TBL] [Abstract][Full Text] [Related]
17. Angiopoietin-like protein 2 increases renal fibrosis by accelerating transforming growth factor-β signaling in chronic kidney disease.
Morinaga J; Kadomatsu T; Miyata K; Endo M; Terada K; Tian Z; Sugizaki T; Tanigawa H; Zhao J; Zhu S; Sato M; Araki K; Iyama K; Tomita K; Mukoyama M; Tomita K; Kitamura K; Oike Y
Kidney Int; 2016 Feb; 89(2):327-41. PubMed ID: 26806834
[TBL] [Abstract][Full Text] [Related]
18. Transforming growth factor-beta receptors in self-limited vs. chronic progressive nephritis in rats.
Watanabe T; Yamamoto T; Ikegaya N; Fujigaki Y; Suzuki H; Togawa A; Fukasawa H; Nagase M; Hishida A
J Pathol; 2002 Nov; 198(3):397-406. PubMed ID: 12375273
[TBL] [Abstract][Full Text] [Related]
19. A comparative study of chronic kidney disease in dogs and cats: induction of cyclooxygenases.
Yabuki A; Mitani S; Sawa M; Mizukami K; Fujiki M; Yamato O
Res Vet Sci; 2012 Oct; 93(2):892-7. PubMed ID: 22244709
[TBL] [Abstract][Full Text] [Related]
20. Acute nephrotoxicity of tacrolimus and sirolimus in renal isografts: differential intragraft expression of transforming growth factor-beta1 and alpha-smooth muscle actin.
Ninova D; Covarrubias M; Rea DJ; Park WD; Grande JP; Stegall MD
Transplantation; 2004 Aug; 78(3):338-44. PubMed ID: 15316360
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
